Thursday, December 20, 2018 8:17:43 AM
I can only offer speculation on whether PLX-PAD can dissolve/lyse existing plaques/fat deposits in the artery. We know that the explicit claim made by Pluristem lists a number of benefits, including angiogenesis, reduction of inflammation, and stimulus of muscle regeneration. This clearly results in healthier tissue, which may have a beneficial effect on larger blockages, BUT the company makes no such claim.
Jonny says:
It might also be the case that after PLX-PAD treatment, the current SOC, surgery to unblock arteries becomes more plausible, given that you now have a much healthier patient, with better tissue surrounding the blocked large artery. All speculation, since no such claims have been made. Perhaps this is an evolving question, and the answer will come from empirical observation in the clinic.
Note that an affirmative answer (yes, PLX-PAD dissolves or stabilizes plaques) would have huge implications for treating arterial diseases in addition to PAD, and the target population would increase substantially (not that they need it, CLI patients are in the millions in this country alone).
My best guess is that we will see a broadening of the therapeutic use of PLX-PAD, beyond CLI and into a more general use for stabilizing and improving the condition of a broad range of CV diseases.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM